The first and only heart failure monitoring solution to noninvasively determine Pulmonary Capillary Wedge Pressure (PCWP) at the point of care.
Current practice of exam, symptoms, and natriuretic peptides miss roughly half of all heart failure patients being discharged with residual congestion — a top predictor of 30- to 90-day readmissions.1
1 Girerd N et al. Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey. JACC Heart Fail. 2018 Apr;6(4):273-285. doi: 10.1016/j.jchf.2017.09.023. Epub 2017 Dec 6. PMID: 29226815.
2 Jencks SF et al. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009 Apr 2;360(14):1418-28. doi: 10.1056/NEJMsa0803563. Erratum in: N Engl J Med. 2011 Apr 21;364(16):1582. PMID: 19339721.
2-minute recording on a rechargeable, wearable sensor delivers an immediate, objective PCWP reading. No catheter. No implant.
Rapidly evaluate heart failure at point-of-care and start therapy sooner.
Optimize protocols and make discharge decisions with confidence.
Catch subclinical congestion and uptitrate GDMT with hemodynamic clarity.
We’d love to meet you this fall. Find us on the exhibit floor for a live CardioTag™ recording, or set up time with our team in advance.
The Ritz-Carlton · Chicago, IL
Exhibit booth
The 3rd annual national forum focused solely on hemodynamics
McCormick Place · Chicago, IL
Booth 748
SHF2 study data presented Sun Nov 8, 9:15 am — Moderated Digital Poster 14
Spot worsening heart failure before symptoms escalate.
Enable timely, data-driven clinical decisions.
Gold-standard congestion data at point of care.
Validated insights for more informed decisions.
Chief Executive Officer
Chief Medical Officer
Co-founder, Chief Scientific Officer
Co-founder, Chief Technical Officer
Chief Regulatory & Compliance Officer
Vice President, Commercial
Co-founder, Advisor
Co-founder, Head of AI
